Literature DB >> 12816753

Myogenic and structural properties of cerebral arteries from the stroke-prone spontaneously hypertensive rat.

Ashley S Izzard1, Delyth Graham, Matthew P Burnham, Egidius H Heerkens, Anna F Dominiczak, Anthony M Heagerty.   

Abstract

The aims of the study were to compare the myogenic and structural properties of middle cerebral arteries (MCAs) from the stroke-prone spontaneously hypertensive rat (SHRSP) with MCAs from the spontaneously hypertensive rat (SHR) before stroke development in SHRSP. Rats were fed a "Japanese" diet (low-protein rat chow and 1% NaCl in drinking water) for 8 wk, and cerebral arteries were studied in vitro at 12 wk using a pressure arteriograph. Systolic pressure was significantly increased in SHRSP compared with SHR at 12 wk. Between 60 and 180 mmHg, MCAs from SHR maintained an essentially constant diameter, i.e., displayed a "myogenic range," whereas the diameter of MCAs from SHRSP progressively increased as a function of pressure. Passive lumen diameter of MCAs from SHRSP was reduced at high pressure, and wall thickness and wall/lumen were increased, compared with SHR. Wall cross-sectional area was also increased in MCAs from SHRSP compared with the SHR, indicating growth. The stress-strain relationship was shifted to the left in MCAs from SHRSP, indicating decreased MCA distensibility compared with SHR. However, collagen staining with picrosirius red revealed a redistribution of collagen to the outer half of the MCA wall in SHRSP compared with SHR. These data demonstrate impaired myogenic properties in prestroke SHRSP compared with SHR, which may explain stroke development. The structural differences in MCAs from SHRSP compared with SHR were a consequence of both growth and a reduced distensibility.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816753     DOI: 10.1152/ajpheart.00352.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  23 in total

Review 1.  Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain?

Authors:  Anne Joutel; Iman Haddad; Julien Ratelade; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.

Authors:  Christine' S Rigsby; David M Pollock; Anne M Dorrance
Journal:  Microvasc Res       Date:  2007-01-23       Impact factor: 3.514

4.  Susceptibility to Hypertensive Renal Disease in the Spontaneously Hypertensive Rat Is Influenced by 2 Loci Affecting Blood Pressure and Immunoglobulin Repertoire.

Authors:  Isha S Dhande; Stacy M Cranford; Yaming Zhu; Sterling C Kneedler; M John Hicks; Scott E Wenderfer; Michael C Braun; Peter A Doris
Journal:  Hypertension       Date:  2018-02-05       Impact factor: 10.190

Review 5.  Aldosterone: good guy or bad guy in cerebrovascular disease?

Authors:  Christiné S Rigsby; William E Cannady; Anne M Dorrance
Journal:  Trends Endocrinol Metab       Date:  2005-10-06       Impact factor: 12.015

6.  Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension.

Authors:  Christiné S Rigsby; Adviye Ergul; Vera Portik Dobos; David M Pollock; Anne M Dorrance
Journal:  Am J Hypertens       Date:  2011-02-24       Impact factor: 2.689

7.  Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats.

Authors:  Paulo W Pires; Curt T Rogers; Jonathon L McClain; Hannah S Garver; Gregory D Fink; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-06       Impact factor: 4.733

Review 8.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

9.  Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.

Authors:  Alexis N Simpkins; R Daniel Rudic; Derek A Schreihofer; Sid Roy; Marlina Manhiani; Hsing-Ju Tsai; Bruce D Hammock; John D Imig
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

Review 10.  Is the mineralocorticoid receptor a potential target for stroke prevention?

Authors:  Jessica M Osmond; Christine' S Rigsby; Anne M Dorrance
Journal:  Clin Sci (Lond)       Date:  2008-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.